Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 21 -30 of 49 Show results per page	View Search Criteria \| Help With Results


21.		Phase II Immunotherapy with Intravenous IFN-beta-ser in Patients with Kaposi's Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								CHSF-85039 NCI-V86-0123


22.		Phase II Immunotherapy with Escalating Doses of IFN-beta-ser Given Intravenously in Patients with Advanced Renal Cell Carcinoma, Melanoma, or non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18								WCCC-CO-8695 NCI-V86-0149

Last Modified: 6/1/1988


23.		Phase II Randomized Study of Immunotherapy with IL-2 vs IL-2/b-IFN in Patients with Refractory or Relapsed non-Hodgkin's Lymphoma (Summary Last Modified 06/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 15				NCI				CLB-8653 CALGB-8653

Last Modified: 9/15/2006


24.		Phase II Master Protocol for the Evaluation of New Treatments in Patients with Advanced Soft Tissue Sarcomas --- MEN vs IFN-beta-ser

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				14 and over				NCI				EST-1785 EST-1785

Last Modified: 11/1/1987


25.		Phase II Immunotherapy with Subcutaneous IFN-beta-ser in Patients with Chronic Myelogenous Leukemia (Summary Last Modified 11/87)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				21 and over								UCLA-8611546 NCI-V87-0184

Last Modified: 10/1/1988


26.		Phase II Randomized Study of Recombinant Interleukin-2 with and without Recombinant Beta Interferon in Patients with Advanced non-Small Cell Lung Cancer (Summary Last Modified 10/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				EST-PZ-586 EST-P-Z586


27.		Phase II Immunotherapy with High-Dose Intravenous Beta-Serine Interferon in Patients with Renal Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								UCLA-87010001 NCI-V87-0211

Last Modified: 9/1/1987


28.		Phase II Master Protocol for Treatment of Advanced non-Small Cell Lung Cancer --- rIFN-b (Summary Last Modified 09/87)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				CLB-8735 CALGB-8735

Last Modified: 6/1/1988


29.		Phase II Combination Immunotherapy with IFN-Gamma/IFN-Beta-Ser in Patients with Metastatic non-Small Cell Lung Cancer (Summary Last Modified 06/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				EST-PY-586 EST-P-Y586

Last Modified: 4/1/1988


30.		Phase II Evaluation of Intravenous IFN-beta-ser in Patients with Advanced Colorectal Carcinoma (Summary Last Modified 04/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				any age								WCCC-CO-8622 NCI-V87-0177

Select All on One Page


					< Previous 1 2 3 4 5 Next >

| | | | | | | |

A Service of the National Cancer Institute